Press Articles RSS



New Optima NMN-C® supplements to boost NAD+ levels, Elevant founder breaks down the facts around NMN purity

New Optima NMN-C® supplements to boost NAD+ levels, Elevant founder breaks down the facts around NMN purity Lifespan innovation website Longevity Technology reported in August 2021 on the impending launch of Elevant’s new Optima NMN-C tablets. In response to market feedback which highlighted that purity of NAD+ boosters is a significant concern for consumers, they also sought the perspective of Elevant founder Guillaume Bermond on the topic of pure NMN. READ FULL ARTICLE

Continue reading



NMN TRANSPORTER SLC12A8 AND THE FUTURE OF NMN CLINICAL TRIALS WITH DR ALESSIA GROZIO

THE NEED FOR NMN CLINICAL TRIALS In a recent post, we discussed a key barrier in our knowledge of NMN supplementation in humans - namely the very limited clinical trial data.  However, this barrier is soon to be removed, thanks to high profile research + business collaborations which a directly confronting this lack of information. With their execution and success, we will soon have a clear understanding of the benefits of NMN supplementation in human subjects (well beyond simpler experimental results, such as how NMN improved our Founder Nick’s biological age by 3.5 years). COLLABORATIONS ON NMN CLINICAL RESEARCH One such collaboration we recently highlighted was the the work between aging research leader the Buck Institute, Elevant, and its parent...

Continue reading



Cellular aging category heats up with new NMN product launch

Developed in collaboration with scientists at the Buck Institute for Research on Aging, the new product called Elevant Prime is formulated with nicotinamide mononucleotide (NMN). French entrepreneur Guillaume Bermond founded Seneque in 2018, and the company is focused on consumer products for NMN, including dietary supplements, cosmetics, and pets. The name ‘Seneque’ comes from Seneca the Younger, a Roman philosopher who encouraged people to discover vitality using their inner resources. READ FULL ARTICLE

Continue reading



Vitamin consumers turn to Seneque’s NMN supplements to boost cellular health

Growing popularity for cellular health is not just coming from seniors intent on staying well as they age, but also from younger demographic groups who are looking to fortify their health in the years ahead.  This is according to Guillaume Bermond, founder of Seneque, an international biotechnology company, discussing the latest trends surrounding nicotinamide mononucleotide (NMN) and cellular health with NutritionInsight. “We hear from people who usually take vitamin supplements telling us they are turning to [Seneque’s NMN supplements] looking for something that works at a cellular level to support health and well-being,” he says. READ FULL ARTICLE

Continue reading